• Skip to primary navigation
  • Skip to main content
SRI logo
  • About
    • Press room
    • Our history
  • Expertise
    • Advanced imaging systems
    • Artificial intelligence
    • Biomedical R&D services
    • Biomedical sciences
    • Computer vision
    • Cyber & formal methods
    • Education and learning
    • Innovation strategy and policy
    • National security
    • Ocean & space
    • Quantum
    • Robotics, sensors & devices
    • Speech & natural language
    • Video test & measurement
  • Ventures
  • NSIC
  • Careers
  • Contact
  • 日本支社
Search
Close
Bios September 8, 2021

Michael McGuire

Research Scientist, Brown Laboratory, Macromolecular Sciences

Michael McGuire, Ph.D.’s research interests include isolating cell-specific binding reagents and using them in diagnostic and therapeutic applications. At SRI, he is helping move peptide ligands into clinical applications for laboratory diagnosis, in vivo imaging and therapy.

McGuire spent 30 years at UT Southwestern Medical Center before moving to SRI. McGuire pursued his interest in proteolytic enzymes under postdoctoral studies with George DeMartino. His work yielded the first purification of the human proteosome (macropain) and characterization of the role of the proteosome in ATP-regulated protein breakdown. After completion of his postdoctoral work, he studied dipeptidyl peptidase I (cathepsin C) and established the role of dipeptidyl peptidase I (DPPI) in processing and activating many of the serine proteases (cathepsin G, elastase, granzymes) present in the granules of white blood cells.

McGuire departed from his protease studies when he joined the Center for Biomedical Invention at UT Southwestern. There, he was responsible for generation of random genomic libraries from various pathogens as part of a strategy to identify new vaccine candidates using expression library immunization. He also ran the center’s DNA sequencing core for center members. During this time, he sequenced the genome of the parapox virus and, using expression-based screening methods, identified two adjuvants from the virus.

McGuire later joined Kathlynn Brown’s group at UT Southwestern. There, he used phage display biopanning to isolate novel peptide ligands that bind specific cell types and are internalized by those cells. As a member of Brown’s group at UT Southwestern and at SRI, he has helped isolate and characterize peptide ligands for a variety of cell types, including B cell lymphomas, myocardiocytes, dendritic cells and non-small cell lung cancers.

McGuire’s Ph.D. in basic medical sciences is from the University of South Alabama College of Medicine. His dissertation work focused on the purification and characterization of proteolytic enzymes in the laboratory of Roger Lane.

He has co-authored 40 research articles and one book chapter, and has obtained four patents.

View selected publications on Google Scholar.

Career call to action image

Work with us

Search jobs

How can we help?

Once you hit send…

We’ll match your inquiry to the person who can best help you.

Expect a response within 48 hours.

Our work

Case studies

Publications

Timeline of innovation

Areas of expertise

Institute

Leadership

Press room

Media inquiries

Compliance

Careers

Job listings

Contact

SRI Ventures

Our locations

Headquarters

333 Ravenswood Ave
Menlo Park, CA 94025 USA

+1 (650) 859-2000

Subscribe to our newsletter


日本支社
SRI International
  • Contact us
  • Privacy Policy
  • Cookies
  • DMCA
  • Copyright © 2023 SRI International
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}